• If you are trying to figure out whether Cimpress at around US$74 per share still offers value, you will want to see how the current price lines up against different valuation checks.
• The stock has seen a mix of moves recently, with a 1.8% decline over the past week and a 6.9% decline over the past month, while still showing returns of 13.1% year to date and 37.9% over the past year.
• Investors have been reacting to ongoing business updates and broader sentiment around Cimpress, which have helped frame expectations around its long term prospects and risk profile. These context shifts can influence how comfortable the market feels with the current share price, even before you look at detailed valuation work.
• Right now, Cimpress has a valuation score of 2 out of 6, which suggests some checks indicate potential undervaluation while others do not. Next, we will compare several common valuation approaches and then finish by looking at a more complete way to judge value that goes beyond any single metric.

Cimpress scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Cimpress Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes the cash Cimpress is expected to generate in the future and discounts those projections back to what they could be worth in today’s dollars.

For Cimpress, the latest twelve month Free Cash Flow is about $163.7 million. Using a 2 Stage Free Cash Flow to Equity model, analysts have explicit projections out to 2030, with Simply Wall St extrapolating beyond the initial analyst horizon. By 2030, projected Free Cash Flow is $314.3 million, with intermediate yearly projections between 2026 and 2035 all feeding into the model in discounted form.

When these projected cash flows are added up and discounted, the estimated intrinsic value comes out to around $198.17 per share. At a current share price of about US$74, this implies an intrinsic discount of roughly 62.5%, indicating that Cimpress is trading at a substantial discount to this cash flow based estimate.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Cimpress is undervalued by 62.5%. Track this in your watchlist or portfolio, or discover 53 more high quality undervalued stocks.

Approach 2: Cimpress Price vs Earnings

For a profitable company, the P/E ratio is a straightforward way to connect what you pay for the stock with the earnings it generates. It tells you how many dollars investors are currently willing to pay for each dollar of earnings.

What counts as a “normal” P/E often reflects the market’s expectations for future growth and perceived risk. Higher expected growth or lower perceived risk can justify a higher P/E, while lower growth expectations or higher perceived risk usually point to a lower P/E.

Cimpress is currently trading on a P/E of 77x. That is above both the Commercial Services industry average P/E of 25.67x and a peer average of 16.50x. Simply Wall St also calculates a proprietary “Fair Ratio” of 32.40x for Cimpress, which is the P/E level implied by factors such as its earnings growth profile, industry, profit margins, market cap and key risks.

This Fair Ratio can be more useful than a simple comparison with peers or the industry because it is tailored to Cimpress, rather than assuming all companies should trade on similar multiples.

With a current P/E of 77x compared with a Fair Ratio of 32.40x, Cimpress looks expensive on this earnings based check.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 23 top founder-led companies.

Upgrade Your Decision Making: Choose your Cimpress Narrative

Earlier we mentioned that there is an even better way to understand valuation. Think of a Narrative as your own Cimpress story that connects what you believe about its shift toward higher value products, margins and cash flows to a clear forecast and fair value on Simply Wall St’s Community page. It then lets you compare that fair value with the current price to decide whether Cimpress looks attractive or not, with the narrative automatically updating when new earnings, guidance or news arrive. One investor might focus on the analyst consensus fair value of US$91.50 as reasonable, while another more cautious investor might lean closer to the US$72.00 price target if they put more weight on execution risks and capital needs.

Do you think there's more to the story for Cimpress? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.